These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8144211)

  • 21. Behaviour of the transgenic (mREN2)27 rat.
    Wilson W; Voigt P; Bader M; Marsden CA; Fink H
    Brain Res; 1996 Aug; 729(1):1-9. PubMed ID: 8874871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
    Mervaala EM; Müller DN; Park JK; Schmidt F; Löhn M; Breu V; Dragun D; Ganten D; Haller H; Luft FC
    Hypertension; 1999 Jan; 33(1 Pt 2):389-95. PubMed ID: 9931135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene.
    Moriguchi A; Brosnihan KB; Kumagai H; Ganten D; Ferrario CM
    Am J Physiol; 1994 Apr; 266(4 Pt 2):R1273-9. PubMed ID: 8184972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic rats: new experimental models for the study of candidate genes in hypertension research.
    Paul M; Wagner J; Hoffmann S; Urata H; Ganten D
    Annu Rev Physiol; 1994; 56():811-29. PubMed ID: 8010762
    [No Abstract]   [Full Text] [Related]  

  • 25. Developing transgenic neuropeptide Y rats.
    Michalkiewicz M; Michalkiewicz T
    Methods Mol Biol; 2000; 153():73-89. PubMed ID: 10957986
    [No Abstract]   [Full Text] [Related]  

  • 26. Transgenic animals: new approaches to hypertension research.
    Mullins JJ; Ganten D
    J Hypertens Suppl; 1990 Dec; 8(7):S35-7. PubMed ID: 2095394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension in the (mRen-2)27 rat is not explained by enhanced kinetics of transgenic Ren-2 renin.
    Rong P; Campbell DJ; Skinner SL
    Hypertension; 2003 Oct; 42(4):523-7. PubMed ID: 14517223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new transgenic rat model of hepatic steatosis and the metabolic syndrome.
    Qi NR; Wang J; Zidek V; Landa V; Mlejnek P; Kazdová L; Pravenec M; Kurtz TW
    Hypertension; 2005 May; 45(5):1004-11. PubMed ID: 15809359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic rats in hypertension research.
    Wagner J; Zeh K; Paul M
    J Hypertens; 1992 Jul; 10(7):601-5. PubMed ID: 1321185
    [No Abstract]   [Full Text] [Related]  

  • 30. Lighting up the body.
    Chapman T
    Nature; 2003 Oct; 425(6960):867. PubMed ID: 14574417
    [No Abstract]   [Full Text] [Related]  

  • 31. Transgenic animals in hypertension and cardiovascular research.
    Brosnan MJ; Mullins JJ
    Exp Nephrol; 1993; 1(1):3-12. PubMed ID: 8081950
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased bradykinin and "normal" angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats.
    Campbell DJ; Kelly DJ; Wilkinson-Berka JL; Cooper ME; Skinner SL
    Kidney Int; 1999 Jul; 56(1):211-21. PubMed ID: 10411695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The renin-angiotensin system in transgenic rats: characteristics and functional studies.
    Wagner J; Ganten D
    Semin Nephrol; 1993 Nov; 13(6):586-92. PubMed ID: 8278693
    [No Abstract]   [Full Text] [Related]  

  • 34. Developmental studies demonstrate age-dependent elevation of renin activity in TGR(mRen2)27 rats.
    Véniant M; Whitworth CE; Ménard J; Sharp MG; Gonzales MF; Bruneval P; Mullins JJ
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1167-76. PubMed ID: 8998250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin resistance and hypertension: studies in transgenic hypertensive TGR(mREN-2)27 rats.
    Vettor R; Cusin I; Ganten D; Rohner-Jeanrenaud F; Ferrannini E; Jeanrenaud B
    Am J Physiol; 1994 Dec; 267(6 Pt 2):R1503-9. PubMed ID: 7810759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetically altered rodent models in the endothelin-related genes].
    Emoto N; Yokoyama M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():311-5. PubMed ID: 16897870
    [No Abstract]   [Full Text] [Related]  

  • 37. Transgenics and essential hypertension.
    Mullins LJ; Morley SD; Mullins JJ
    J Hum Hypertens; 1996 Oct; 10(10):627-31. PubMed ID: 9004085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.
    Mitchell KD; Jacinto SM; Mullins JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F246-53. PubMed ID: 9277585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic models of hypertension in experimental animals.
    Yagil Y; Yagil C
    Exp Nephrol; 2001; 9(1):1-9. PubMed ID: 11053974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes.
    Mervaala EM; Cheng ZJ; Tikkanen I; Lapatto R; Nurminen K; Vapaatalo H; Müller DN; Fiebeler A; Ganten U; Ganten D; Luft FC
    Hypertension; 2001 Feb; 37(2 Pt 2):414-8. PubMed ID: 11230310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.